Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-17

Clinical Trial Update: Helicobacter Eradication Aspirin Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Helicobacter eradication in the context of gastrointestinal ulcer hemorrhage and H. pylori infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Nottingham | Conditions: Gastrointestinal Ulcer Haemorrhage, Bacterial Infection Due to Helicobacter Pylori (H. Pylori) | Phase 4 | Status: COMPLETED